Development of κ opioid receptor antagonists. | Semantic Scholar
The G protein-first activation mechanism of opioid receptors by Gi protein and agonists | QRB Discovery | Cambridge Core
κ-opioid receptor - Wikipedia
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Diverse Kappa Opioid Receptor Agonists: Relationships Between Signaling and Behavior
Delta-Opioid Receptor Analgesia Is Independent of Microglial Activation in a Rat Model of Neuropathic Pain | PLOS ONE
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Table II from Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. | Semantic Scholar
Opioid Receptor | kappa, mu Opioid Receptor
Chemotype-selective Modes of Action of κ-Opioid Receptor Agonists* - Journal of Biological Chemistry
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | SpringerLink
Understanding opioids in veterinary medicine
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Peptide Analgesics – Opioid Peptides
Molecules | Free Full-Text | Antipruritic Effect of Nalbuphine, a Kappa Opioid Receptor Agonist, in Mice: A Pan Antipruritic
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
Molecular switches of the κ opioid receptor triggered by 6′-GNTI and 5′-GNTI | Scientific Reports
Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain
Scientists Just Solved a Major Piece of the Opioid Puzzle | WIRED
Opioid Receptors Mnemonic | Epomedicine
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists | HTML
Opioids in cancer: The κ‑opioid receptor (Review)
Strategies for Developing κ Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects | Journal of Pharmacology and Experimental Therapeutics